スコポラミンブチルブロマイドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Scopolamine Butylbromide Market Insights, Forecast to 2028

• レポートコード：QY2203B03394 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のスコポラミンブチルブロマイドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスコポラミンブチルブロマイドの世界市場のxxx％を占める「錠剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のスコポラミンブチルブロマイドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのスコポラミンブチルブロマイド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのスコポラミンブチルブロマイド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 スコポラミンブチルブロマイドのグローバル主要メーカーには、AdvaCare Pharma、Boehringer-Ingelheim、AlchemInternational、RHR MEDICARE PVT LTD、Baiyunshan Pharmaceutical Holdings、XABC、Shuangcheng Pharma、Chengdu Tiantai Mount pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 スコポラミンブチルブロマイド市場は、種類と用途によって区分されます。世界のスコポラミンブチルブロマイド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 錠剤、カプセル、注射器 【用途別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - スコポラミンブチルブロマイド製品概要 - 種類別市場（錠剤、カプセル、注射器） - 用途別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のスコポラミンブチルブロマイド販売量予測2017-2028 - 世界のスコポラミンブチルブロマイド売上予測2017-2028 - スコポラミンブチルブロマイドの地域別販売量 - スコポラミンブチルブロマイドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別スコポラミンブチルブロマイド販売量 - 主要メーカー別スコポラミンブチルブロマイド売上 - 主要メーカー別スコポラミンブチルブロマイド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（錠剤、カプセル、注射器） - スコポラミンブチルブロマイドの種類別販売量 - スコポラミンブチルブロマイドの種類別売上 - スコポラミンブチルブロマイドの種類別価格 ・用途別市場規模（病院薬局、小売店薬局、その他） - スコポラミンブチルブロマイドの用途別販売量 - スコポラミンブチルブロマイドの用途別売上 - スコポラミンブチルブロマイドの用途別価格 ・北米市場 - 北米のスコポラミンブチルブロマイド市場規模（種類別、用途別） - 主要国別のスコポラミンブチルブロマイド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのスコポラミンブチルブロマイド市場規模（種類別、用途別） - 主要国別のスコポラミンブチルブロマイド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のスコポラミンブチルブロマイド市場規模（種類別、用途別） - 主要国別のスコポラミンブチルブロマイド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のスコポラミンブチルブロマイド市場規模（種類別、用途別） - 主要国別のスコポラミンブチルブロマイド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのスコポラミンブチルブロマイド市場規模（種類別、用途別） - 主要国別のスコポラミンブチルブロマイド市場規模（トルコ、サウジアラビア） ・企業情報 AdvaCare Pharma、Boehringer-Ingelheim、AlchemInternational、RHR MEDICARE PVT LTD、Baiyunshan Pharmaceutical Holdings、XABC、Shuangcheng Pharma、Chengdu Tiantai Mount pharmaceutical ・産業チェーン及び販売チャネル分析 - スコポラミンブチルブロマイドの産業チェーン分析 - スコポラミンブチルブロマイドの原材料 - スコポラミンブチルブロマイドの生産プロセス - スコポラミンブチルブロマイドの販売及びマーケティング - スコポラミンブチルブロマイドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - スコポラミンブチルブロマイドの産業動向 - スコポラミンブチルブロマイドのマーケットドライバー - スコポラミンブチルブロマイドの課題 - スコポラミンブチルブロマイドの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Scopolamine Butylbromide Market
Due to the COVID-19 pandemic, the global Scopolamine Butylbromide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tablet accounting for % of the Scopolamine Butylbromide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Scopolamine Butylbromide market size is valued at US$ million in 2021, while the US and Europe Scopolamine Butylbromide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Scopolamine Butylbromide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Scopolamine Butylbromide include AdvaCare Pharma, Boehringer-Ingelheim, AlchemInternational, RHR MEDICARE PVT LTD, Baiyunshan Pharmaceutical Holdings, XABC, Shuangcheng Pharma and Chengdu Tiantai Mount pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Scopolamine Butylbromide Scope and Segment
Scopolamine Butylbromide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Scopolamine Butylbromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
AdvaCare Pharma
Boehringer-Ingelheim
AlchemInternational
RHR MEDICARE PVT LTD
Baiyunshan Pharmaceutical Holdings
XABC
Shuangcheng Pharma
Chengdu Tiantai Mount pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Scopolamine Butylbromide Product Introduction
1.2 Market by Type
1.2.1 Global Scopolamine Butylbromide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Scopolamine Butylbromide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Scopolamine Butylbromide Sales Estimates and Forecasts 2017-2028
2.2 Global Scopolamine Butylbromide Revenue Estimates and Forecasts 2017-2028
2.3 Global Scopolamine Butylbromide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Scopolamine Butylbromide Sales by Region
2.4.1 Global Scopolamine Butylbromide Sales by Region (2017-2022)
2.4.2 Global Sales Scopolamine Butylbromide by Region (2023-2028)
2.5 Global Scopolamine Butylbromide Revenue by Region
2.5.1 Global Scopolamine Butylbromide Revenue by Region (2017-2022)
2.5.2 Global Scopolamine Butylbromide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Scopolamine Butylbromide Sales by Manufacturers
3.1.1 Global Top Scopolamine Butylbromide Manufacturers by Sales (2017-2022)
3.1.2 Global Scopolamine Butylbromide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Scopolamine Butylbromide in 2021
3.2 Global Scopolamine Butylbromide Revenue by Manufacturers
3.2.1 Global Scopolamine Butylbromide Revenue by Manufacturers (2017-2022)
3.2.2 Global Scopolamine Butylbromide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Scopolamine Butylbromide Revenue in 2021
3.3 Global Scopolamine Butylbromide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Scopolamine Butylbromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Scopolamine Butylbromide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Scopolamine Butylbromide Sales by Type
4.1.1 Global Scopolamine Butylbromide Historical Sales by Type (2017-2022)
4.1.2 Global Scopolamine Butylbromide Forecasted Sales by Type (2023-2028)
4.1.3 Global Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
4.2 Global Scopolamine Butylbromide Revenue by Type
4.2.1 Global Scopolamine Butylbromide Historical Revenue by Type (2017-2022)
4.2.2 Global Scopolamine Butylbromide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
4.3 Global Scopolamine Butylbromide Price by Type
4.3.1 Global Scopolamine Butylbromide Price by Type (2017-2022)
4.3.2 Global Scopolamine Butylbromide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Scopolamine Butylbromide Sales by Application
5.1.1 Global Scopolamine Butylbromide Historical Sales by Application (2017-2022)
5.1.2 Global Scopolamine Butylbromide Forecasted Sales by Application (2023-2028)
5.1.3 Global Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
5.2 Global Scopolamine Butylbromide Revenue by Application
5.2.1 Global Scopolamine Butylbromide Historical Revenue by Application (2017-2022)
5.2.2 Global Scopolamine Butylbromide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
5.3 Global Scopolamine Butylbromide Price by Application
5.3.1 Global Scopolamine Butylbromide Price by Application (2017-2022)
5.3.2 Global Scopolamine Butylbromide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Scopolamine Butylbromide Market Size by Type
6.1.1 North America Scopolamine Butylbromide Sales by Type (2017-2028)
6.1.2 North America Scopolamine Butylbromide Revenue by Type (2017-2028)
6.2 North America Scopolamine Butylbromide Market Size by Application
6.2.1 North America Scopolamine Butylbromide Sales by Application (2017-2028)
6.2.2 North America Scopolamine Butylbromide Revenue by Application (2017-2028)
6.3 North America Scopolamine Butylbromide Market Size by Country
6.3.1 North America Scopolamine Butylbromide Sales by Country (2017-2028)
6.3.2 North America Scopolamine Butylbromide Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Scopolamine Butylbromide Market Size by Type
7.1.1 Europe Scopolamine Butylbromide Sales by Type (2017-2028)
7.1.2 Europe Scopolamine Butylbromide Revenue by Type (2017-2028)
7.2 Europe Scopolamine Butylbromide Market Size by Application
7.2.1 Europe Scopolamine Butylbromide Sales by Application (2017-2028)
7.2.2 Europe Scopolamine Butylbromide Revenue by Application (2017-2028)
7.3 Europe Scopolamine Butylbromide Market Size by Country
7.3.1 Europe Scopolamine Butylbromide Sales by Country (2017-2028)
7.3.2 Europe Scopolamine Butylbromide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Scopolamine Butylbromide Market Size by Type
8.1.1 Asia Pacific Scopolamine Butylbromide Sales by Type (2017-2028)
8.1.2 Asia Pacific Scopolamine Butylbromide Revenue by Type (2017-2028)
8.2 Asia Pacific Scopolamine Butylbromide Market Size by Application
8.2.1 Asia Pacific Scopolamine Butylbromide Sales by Application (2017-2028)
8.2.2 Asia Pacific Scopolamine Butylbromide Revenue by Application (2017-2028)
8.3 Asia Pacific Scopolamine Butylbromide Market Size by Region
8.3.1 Asia Pacific Scopolamine Butylbromide Sales by Region (2017-2028)
8.3.2 Asia Pacific Scopolamine Butylbromide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Scopolamine Butylbromide Market Size by Type
9.1.1 Latin America Scopolamine Butylbromide Sales by Type (2017-2028)
9.1.2 Latin America Scopolamine Butylbromide Revenue by Type (2017-2028)
9.2 Latin America Scopolamine Butylbromide Market Size by Application
9.2.1 Latin America Scopolamine Butylbromide Sales by Application (2017-2028)
9.2.2 Latin America Scopolamine Butylbromide Revenue by Application (2017-2028)
9.3 Latin America Scopolamine Butylbromide Market Size by Country
9.3.1 Latin America Scopolamine Butylbromide Sales by Country (2017-2028)
9.3.2 Latin America Scopolamine Butylbromide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Scopolamine Butylbromide Market Size by Type
10.1.1 Middle East and Africa Scopolamine Butylbromide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Scopolamine Butylbromide Revenue by Type (2017-2028)
10.2 Middle East and Africa Scopolamine Butylbromide Market Size by Application
10.2.1 Middle East and Africa Scopolamine Butylbromide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Scopolamine Butylbromide Revenue by Application (2017-2028)
10.3 Middle East and Africa Scopolamine Butylbromide Market Size by Country
10.3.1 Middle East and Africa Scopolamine Butylbromide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Scopolamine Butylbromide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AdvaCare Pharma
11.1.1 AdvaCare Pharma Corporation Information
11.1.2 AdvaCare Pharma Overview
11.1.3 AdvaCare Pharma Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AdvaCare Pharma Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AdvaCare Pharma Recent Developments
11.2 Boehringer-Ingelheim
11.2.1 Boehringer-Ingelheim Corporation Information
11.2.2 Boehringer-Ingelheim Overview
11.2.3 Boehringer-Ingelheim Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boehringer-Ingelheim Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer-Ingelheim Recent Developments
11.3 AlchemInternational
11.3.1 AlchemInternational Corporation Information
11.3.2 AlchemInternational Overview
11.3.3 AlchemInternational Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AlchemInternational Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AlchemInternational Recent Developments
11.4 RHR MEDICARE PVT LTD
11.4.1 RHR MEDICARE PVT LTD Corporation Information
11.4.2 RHR MEDICARE PVT LTD Overview
11.4.3 RHR MEDICARE PVT LTD Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 RHR MEDICARE PVT LTD Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 RHR MEDICARE PVT LTD Recent Developments
11.5 Baiyunshan Pharmaceutical Holdings
11.5.1 Baiyunshan Pharmaceutical Holdings Corporation Information
11.5.2 Baiyunshan Pharmaceutical Holdings Overview
11.5.3 Baiyunshan Pharmaceutical Holdings Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Baiyunshan Pharmaceutical Holdings Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baiyunshan Pharmaceutical Holdings Recent Developments
11.6 XABC
11.6.1 XABC Corporation Information
11.6.2 XABC Overview
11.6.3 XABC Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 XABC Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 XABC Recent Developments
11.7 Shuangcheng Pharma
11.7.1 Shuangcheng Pharma Corporation Information
11.7.2 Shuangcheng Pharma Overview
11.7.3 Shuangcheng Pharma Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shuangcheng Pharma Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shuangcheng Pharma Recent Developments
11.8 Chengdu Tiantai Mount pharmaceutical
11.8.1 Chengdu Tiantai Mount pharmaceutical Corporation Information
11.8.2 Chengdu Tiantai Mount pharmaceutical Overview
11.8.3 Chengdu Tiantai Mount pharmaceutical Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chengdu Tiantai Mount pharmaceutical Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chengdu Tiantai Mount pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Scopolamine Butylbromide Industry Chain Analysis
12.2 Scopolamine Butylbromide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Scopolamine Butylbromide Production Mode & Process
12.4 Scopolamine Butylbromide Sales and Marketing
12.4.1 Scopolamine Butylbromide Sales Channels
12.4.2 Scopolamine Butylbromide Distributors
12.5 Scopolamine Butylbromide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Scopolamine Butylbromide Industry Trends
13.2 Scopolamine Butylbromide Market Drivers
13.3 Scopolamine Butylbromide Market Challenges
13.4 Scopolamine Butylbromide Market Restraints
14 Key Findings in The Global Scopolamine Butylbromide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Scopolamine Butylbromide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Injection
Table 5. Global Scopolamine Butylbromide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Scopolamine Butylbromide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Scopolamine Butylbromide Sales by Region (2017-2022) & (K Units)
Table 8. Global Scopolamine Butylbromide Sales Market Share by Region (2017-2022)
Table 9. Global Scopolamine Butylbromide Sales by Region (2023-2028) & (K Units)
Table 10. Global Scopolamine Butylbromide Sales Market Share by Region (2023-2028)
Table 11. Global Scopolamine Butylbromide Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Scopolamine Butylbromide Revenue Market Share by Region (2017-2022)
Table 13. Global Scopolamine Butylbromide Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Scopolamine Butylbromide Revenue Market Share by Region (2023-2028)
Table 15. Global Scopolamine Butylbromide Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Scopolamine Butylbromide Sales Share by Manufacturers (2017-2022)
Table 17. Global Scopolamine Butylbromide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Scopolamine Butylbromide Revenue Share by Manufacturers (2017-2022)
Table 19. Scopolamine Butylbromide Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Scopolamine Butylbromide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Scopolamine Butylbromide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Butylbromide as of 2021)
Table 22. Scopolamine Butylbromide Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Scopolamine Butylbromide Product Offered
Table 24. Date of Manufacturers Enter into Scopolamine Butylbromide Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 27. Global Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 28. Global Scopolamine Butylbromide Sales Share by Type (2017-2022)
Table 29. Global Scopolamine Butylbromide Sales Share by Type (2023-2028)
Table 30. Global Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Scopolamine Butylbromide Revenue Share by Type (2017-2022)
Table 33. Global Scopolamine Butylbromide Revenue Share by Type (2023-2028)
Table 34. Scopolamine Butylbromide Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Scopolamine Butylbromide Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 37. Global Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 38. Global Scopolamine Butylbromide Sales Share by Application (2017-2022)
Table 39. Global Scopolamine Butylbromide Sales Share by Application (2023-2028)
Table 40. Global Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Scopolamine Butylbromide Revenue Share by Application (2017-2022)
Table 43. Global Scopolamine Butylbromide Revenue Share by Application (2023-2028)
Table 44. Scopolamine Butylbromide Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Scopolamine Butylbromide Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 47. North America Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 48. North America Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 51. North America Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 52. North America Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Scopolamine Butylbromide Sales by Country (2017-2022) & (K Units)
Table 55. North America Scopolamine Butylbromide Sales by Country (2023-2028) & (K Units)
Table 56. North America Scopolamine Butylbromide Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Scopolamine Butylbromide Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 59. Europe Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 60. Europe Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 63. Europe Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 64. Europe Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Scopolamine Butylbromide Sales by Country (2017-2022) & (K Units)
Table 67. Europe Scopolamine Butylbromide Sales by Country (2023-2028) & (K Units)
Table 68. Europe Scopolamine Butylbromide Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Scopolamine Butylbromide Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Scopolamine Butylbromide Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Scopolamine Butylbromide Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Scopolamine Butylbromide Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Scopolamine Butylbromide Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Scopolamine Butylbromide Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Scopolamine Butylbromide Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Scopolamine Butylbromide Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Scopolamine Butylbromide Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Scopolamine Butylbromide Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Scopolamine Butylbromide Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Scopolamine Butylbromide Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Scopolamine Butylbromide Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Scopolamine Butylbromide Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Scopolamine Butylbromide Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Scopolamine Butylbromide Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Scopolamine Butylbromide Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Scopolamine Butylbromide Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Scopolamine Butylbromide Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Scopolamine Butylbromide Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Scopolamine Butylbromide Revenue by Country (2023-2028) & (US$ Million)
Table 106. AdvaCare Pharma Corporation Information
Table 107. AdvaCare Pharma Description and Major Businesses
Table 108. AdvaCare Pharma Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. AdvaCare Pharma Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. AdvaCare Pharma Recent Developments
Table 111. Boehringer-Ingelheim Corporation Information
Table 112. Boehringer-Ingelheim Description and Major Businesses
Table 113. Boehringer-Ingelheim Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Boehringer-Ingelheim Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Boehringer-Ingelheim Recent Developments
Table 116. AlchemInternational Corporation Information
Table 117. AlchemInternational Description and Major Businesses
Table 118. AlchemInternational Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. AlchemInternational Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. AlchemInternational Recent Developments
Table 121. RHR MEDICARE PVT LTD Corporation Information
Table 122. RHR MEDICARE PVT LTD Description and Major Businesses
Table 123. RHR MEDICARE PVT LTD Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. RHR MEDICARE PVT LTD Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. RHR MEDICARE PVT LTD Recent Developments
Table 126. Baiyunshan Pharmaceutical Holdings Corporation Information
Table 127. Baiyunshan Pharmaceutical Holdings Description and Major Businesses
Table 128. Baiyunshan Pharmaceutical Holdings Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Baiyunshan Pharmaceutical Holdings Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Baiyunshan Pharmaceutical Holdings Recent Developments
Table 131. XABC Corporation Information
Table 132. XABC Description and Major Businesses
Table 133. XABC Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. XABC Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. XABC Recent Developments
Table 136. Shuangcheng Pharma Corporation Information
Table 137. Shuangcheng Pharma Description and Major Businesses
Table 138. Shuangcheng Pharma Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Shuangcheng Pharma Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Shuangcheng Pharma Recent Developments
Table 141. Chengdu Tiantai Mount pharmaceutical Corporation Information
Table 142. Chengdu Tiantai Mount pharmaceutical Description and Major Businesses
Table 143. Chengdu Tiantai Mount pharmaceutical Scopolamine Butylbromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Chengdu Tiantai Mount pharmaceutical Scopolamine Butylbromide Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Chengdu Tiantai Mount pharmaceutical Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Scopolamine Butylbromide Distributors List
Table 149. Scopolamine Butylbromide Customers List
Table 150. Scopolamine Butylbromide Market Trends
Table 151. Scopolamine Butylbromide Market Drivers
Table 152. Scopolamine Butylbromide Market Challenges
Table 153. Scopolamine Butylbromide Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Scopolamine Butylbromide Product Picture
Figure 3. Global Scopolamine Butylbromide Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Scopolamine Butylbromide Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Others
Figure 10. Scopolamine Butylbromide Report Years Considered
Figure 11. Global Scopolamine Butylbromide Sales 2017-2028 (K Units)
Figure 12. Global Scopolamine Butylbromide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Scopolamine Butylbromide Revenue 2017-2028 (US$ Million)
Figure 14. Global Scopolamine Butylbromide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Scopolamine Butylbromide Sales Market Share by Region (2017-2022)
Figure 16. Global Scopolamine Butylbromide Sales Market Share by Region (2023-2028)
Figure 17. North America Scopolamine Butylbromide Sales YoY (2017-2028) & (K Units)
Figure 18. North America Scopolamine Butylbromide Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Scopolamine Butylbromide Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Scopolamine Butylbromide Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Scopolamine Butylbromide Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Scopolamine Butylbromide Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Scopolamine Butylbromide Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Scopolamine Butylbromide Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Scopolamine Butylbromide Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Scopolamine Butylbromide Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Scopolamine Butylbromide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Scopolamine Butylbromide in the World: Market Share by Scopolamine Butylbromide Revenue in 2021
Figure 29. Global Scopolamine Butylbromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 31. Global Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 32. Global Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 33. Global Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 34. North America Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 35. North America Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 36. North America Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 37. North America Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 38. North America Scopolamine Butylbromide Sales Share by Country (2017-2028)
Figure 39. North America Scopolamine Butylbromide Revenue Share by Country (2017-2028)
Figure 40. United States Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 43. Europe Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 44. Europe Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 45. Europe Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 46. Europe Scopolamine Butylbromide Sales Share by Country (2017-2028)
Figure 47. Europe Scopolamine Butylbromide Revenue Share by Country (2017-2028)
Figure 48. Germany Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 49. France Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Scopolamine Butylbromide Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Scopolamine Butylbromide Revenue Share by Region (2017-2028)
Figure 59. China Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 62. India Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 69. Latin America Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 71. Latin America Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Scopolamine Butylbromide Sales Share by Country (2017-2028)
Figure 73. Latin America Scopolamine Butylbromide Revenue Share by Country (2017-2028)
Figure 74. Mexico Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Scopolamine Butylbromide Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Scopolamine Butylbromide Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Scopolamine Butylbromide Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Scopolamine Butylbromide Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Scopolamine Butylbromide Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Scopolamine Butylbromide Revenue Share by Country (2017-2028)
Figure 83. Turkey Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Scopolamine Butylbromide Revenue (2017-2028) & (US$ Million)
Figure 86. Scopolamine Butylbromide Value Chain
Figure 87. Scopolamine Butylbromide Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---